Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer

British Journal of Dermatology

Volumn 146, Issue 2, 2002, Pages 178-188

  Ibbotson, S H ^a  

^a NHS TAYSIDE   (United Kingdom)

Author keywords

5 aminolaevulinic acid; Acne; Photodynamic therapy; Psoriasis; T cell lymphoma; Warts

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; KERATOLYTIC AGENT; LACTIC ACID PLUS SALICYLIC ACID; PHOTOFRIN; PHOTOSENSITIZING AGENT; PLACEBO; PROTOPORPHYRIN; UNCLASSIFIED DRUG; VERUCID;

ACNE VULGARIS; BLUE LIGHT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEILITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DEVICE; DRUG EFFICACY; ERYTHROPLASIA; HIRSUTISM; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; NONHUMAN; PAGET SKIN DISEASE; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSORIASIS; RADIATION DOSE; RADIATION RESPONSE; RED LIGHT; REVIEW; SCLERODERMA; SKIN CARCINOMA; T CELL LYMPHOMA; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; VERRUCA VULGARIS; WART VIRUS; WHITE LIGHT;

ACNE VULGARIS; AMINOLEVULINIC ACID; HUMANS; LYMPHOMA, T-CELL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS; SKIN DISEASES; SKIN NEOPLASMS; WARTS;

EID: 0036208516     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-0963.2001.04689.x     Document Type: Review

References (91)

1. Ueber die wirkung fluoreszierenden stoffe auf infusorien
2. Therapeutische versuche mit fluoreszierenden stoffe
3. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience
4. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy
5. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolaevulinic acid sensitisation and laser irradiation
6. Superficial photodynamic therapy with topical 5-aminlaevulinic acid for superficial primary and secondary skin cancer
7. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors
8. Photodynamic therapy for basal cell carcinoma: Effect of tumor thickness and duration of photosensitizer application on response
9. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease
10. Photodynamic therapy in dermatology
11. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research
12. Photodynamic therapy in psoriasis: Suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo
13. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: Randomised double-blind trial
14. Topical photodynamic therapy in verrucae. A pilot study
15. Treatment of recalcitrant verrucae by photodynamic therapy with topical application of delta-amino-laevulinic acid
16. Photodynamic therapy of recalcitrant warts with 5-aminolaevulinic acid: A retrospective analysis
17. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: A pilot study
18. Photodynamic therapy with topical δ-aminolaevulinic acid for the treatment of plantar warts
19. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum
20. An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization
21. Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation
22. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence
23. Behandlung von akne vulgaris mit sichtbarem licht
24. Acnetherapie mit sichbarem licht
25. Phototherapy of acne vulgaris with visible light
26. Phototherapy and acne vulgaris
27. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris
28. Topical ALA-photodynamic therapy for the treatment of acne vulgaris
29. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid
30. Photodynamic therapy of acne vulgaris with topical δ-aminolaevulinic acid and incoherent light in Japanese patients
31. Psoriasis vulgaris treated with hematoporphyrin
32. Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative
33. Photodynamic therapy of psoriasis palmaris et plantaris using a topically applied hematoporphyrin derivative and visible light
34. Anti-psoriasis and phototoxic effect of a hematoporphyrin derivative following topical administration and irradiation with visible light
35. Treatment of psoriasis by topical photodynamic therapy with polychromatic light
36. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy
37. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy
38. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid
39. Photodynamic therapy (PDT) of psoriasis with topical delta aminolaevulinic acid (ALA): A pilot dose-ranging study
40. Improved response of plaque psoriasis after multiple treatment with topical 5-aminolaevulinic acid photodynamic therapy
41. Systemic photodynamic therapy is a safe and effective treatment of psoriasis
42. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma
43. Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX
44. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA)
45. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins
46. Large mutagenic lesions are induced by photodynamic therapy in murine L5178Y lymphoblasts
47. Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro
48. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid
49. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolaevulinic acid
50. Topical 5-aminolaevulinic acid based photodynamic therapy for mycosis fungoides: A study of cell proliferation and apoptosis before and after therapy
51. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application
52. Effects of fluence and intensity in PDT of cutaneous T-cell lymphoma with topical ALA: High intensities spare the epidermis
53. Photodynamic therapy with topical delta-aminolevulinic acid for treatment of cutaneous carcinomas and cutaneous T cell lymphoma
54. Photodynamic therapy of cutaneous T-cell lymphoma at special sites
55. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin
56. The treatment of cutaneous T-cell lymphoma by topical aminolaevulinic acid photodynamic therapy
57. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides
58. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: Clinical and histological response
59. Photodynamic therapy with 5-aminolaevulinic acid in the treatment of actinic cheilitis
60. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy
61. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: A cautionary tale
62. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid
63. The Roswell Park Cancer Institute experience with extramammary Paget's disease
64. Photodynamic therapy for inoperable vulval Paget's disease using delta-aminolaevulinic acid: Successful management of a large skin lesion
65. Photodynamic therapy in the management of neoplasms of the perianal skin
66. Photodynamic therapy for residual neoplasms of the perianal skin
67. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolaevulinic acid
68. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: Implications for photodynamic treatment
69. Photodynamic therapy for condylomata acuminata with local application of 5-aminolaevulinic acid
70. Topical photodynamic therapy for localized scleroderma
71. PDT for hirsutism
72. Photodynamic therapy for nevus sebaceus with topical delta-aminolevulinic acid
73. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy
74. Treatment of lichen planus of the penis with photodynamic therapy
75. Topical hematoporphyrin plus UVA for treatment of alopecia areata
76. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce regrowth in patients with extensive alopecia areata
77. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy
78. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid
79. Photodynamic treatment for lower genital tract intraepithelial neoplasia
80. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid
81. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy
82. In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster
83. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo
84. Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid
85. Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy
86. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid
87. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer
88. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: Increased damage after multiple irradiations
89. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo
90. Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma
91. Photodynamic therapy of cutaneous metastases of breast cancer after local application meso-tetra-(para-sulphophenyl)-porphin (TPPS4)